Operational EfficiencyEnhanced operational efficiency indicates effective management strategies, leading to better resource utilization and cost control, which can drive long-term profitability.

Cash Flow ImprovementPositive operating cash flow reflects strong cash generation, providing the company with greater financial flexibility to invest in growth opportunities and manage liabilities.

Gross Profit Margin GrowthAn increasing gross profit margin suggests better cost management and pricing strategies, enhancing the company's ability to sustain profitability over time.

Bears Say

Declining RevenueA decline in revenue indicates potential challenges in market demand or competitive pressures, which could impact long-term growth prospects if not addressed.

Low ProfitabilityLow profitability margins suggest limited pricing power or high operational costs, which could hinder the company's ability to generate sustainable earnings.

Earnings DeclineA significant decline in earnings per share reflects reduced profitability and may indicate operational or market challenges, affecting investor confidence and future growth.

8257 FAQ

What was Genes Tech Group Holdings Company Limited’s price range in the past 12 months?

Genes Tech Group Holdings Company Limited lowest stock price was HK$0.04 and its highest was HK$0.24 in the past 12 months.

What is Genes Tech Group Holdings Company Limited’s market cap?

Genes Tech Group Holdings Company Limited’s market cap is HK$244.00M.

When is Genes Tech Group Holdings Company Limited’s upcoming earnings report date?

Genes Tech Group Holdings Company Limited’s upcoming earnings report date is Mar 31, 2026 which is in 35 days.

How were Genes Tech Group Holdings Company Limited’s earnings last quarter?

Currently, no data Available

Is Genes Tech Group Holdings Company Limited overvalued?

According to Wall Street analysts Genes Tech Group Holdings Company Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Genes Tech Group Holdings Company Limited pay dividends?

Genes Tech Group Holdings Company Limited pays a Annually dividend of HK$0.012 which represents an annual dividend yield of N/A. See more information on Genes Tech Group Holdings Company Limited dividends here

What is Genes Tech Group Holdings Company Limited’s EPS estimate?

Genes Tech Group Holdings Company Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Genes Tech Group Holdings Company Limited have?

Genes Tech Group Holdings Company Limited has 1,000,000,000 shares outstanding.

What happened to Genes Tech Group Holdings Company Limited’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Genes Tech Group Holdings Company Limited?

Currently, no hedge funds are holding shares in HK:8257

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Genes Tech Group Holdings Company Limited Stock Smart Score

Neutral

Technicals

Fundamentals

Return on Equity

3.83%

Trailing 12-Months

Asset Growth

31.85%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Genes Tech Group Holdings Company Limited

Genes Tech Group Holdings Company Limited (8257) is a biotechnology firm based in Hong Kong, specializing in the development and commercialization of innovative genetic testing and analysis solutions. The company's core offerings include genetic testing services for various health conditions, as well as advanced genomic research technologies aimed at enhancing personalized medicine and improving patient outcomes. Genes Tech operates within the healthcare sector, focusing on the integration of cutting-edge technology with genomic data to provide actionable insights for healthcare providers and patients alike.